ICOS CORP 4
4 · ICOS CORP · Filed Jan 30, 2007
Insider Transaction Report
Form 4
ICOS CORPICOS
WILCOX GARY
DirectorEVP, Operations
Transactions
- Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−234,569$7,975,346→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2007-01-29$34.00/sh−99,899$3,396,566→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$3.69/sh−41,721$153,846→ 0 totalExercise: $30.31From: 2000-01-05Exp: 2010-01-05→ Common Stock (41,721 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$16.94/sh−62,090$1,051,805→ 0 totalExercise: $17.06From: 1998-01-07Exp: 2008-01-07→ Common Stock (62,090 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$4.27/sh−64,300$274,561→ 0 totalExercise: $29.73From: 2002-12-10Exp: 2012-12-10→ Common Stock (64,300 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$6.00/sh−44,291$265,746→ 0 totalExercise: $28.00From: 1999-03-10Exp: 2009-03-10→ Common Stock (44,291 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$8.62/sh−23,900$206,018→ 0 totalExercise: $25.38From: 2005-01-27Exp: 2015-01-27→ Common Stock (23,900 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-01-29$9.11/sh−50,000$455,500→ 0 totalExercise: $24.89From: 2006-01-24Exp: 2016-01-23→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to the Merger Agreement under which Eli Lilly and Company ("Eli Lilly") acquired the Issuer ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for $34.00 per share (the "Merger Consideration). Includes 80,250 shares of unvested restricted stock.
- [F2]Disposed of pursuant to the Merger Agreement ("Merger") and which provides for the cancellation of shares of common stock of the Issuer in exchange for Merger Consideration.
- [F3]The options vested monthly in 1/48th increments over four years (48 months) commencing on the grant date indicated.
- [F4]All options were cancelled pursuant to the Merger Agreement in exchange for cash consideration equal to the Merger Consideration less the exercise price per share.